Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-64

I'm guessing your ignorant of product development in the pharmaceutical industry ??
If indeed ave could prove that a high absorption of cbd mitigated insomnia pharma will go straight to the compound already FDA approved , pharmaceutical grade gmp ready at around one third the price .
If you wish to see a comparison between both solubilizers I suggest you search the Monash mct tpm study .
Unfortunately for investors tpm has never ever thrown tpgs out of the ring . It's just a never ending story of failure .While tpgs thrives tpm is yet to have one commercial successful application and there have been a plethora of attempts . Can't see this being any different .
Just my opinion of course , who knows I might be wrong for the first time on my ave prognosis .